Status:
RECRUITING
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients with Type 2 Diabetes: STRONG-DM Study
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborating Sponsors:
Roche Diagnostics GmbH
Conditions:
Type 2 Diabetes
Diabetic Cardiomyopathy
Eligibility:
All Genders
Phase:
NA
Brief Summary
A pragmatic, randomized clinical trial to evaluate the effect of a heart failure (HF) risk assessment and prevention strategy incorporating HF clinical risk scores (WATCH-DM) with cardiac biomarker (N...
Detailed Description
Primary care providers will be randomized to receive notifications via the electronic health record if any patients with diabetes have high heart failure risk based on a combination of clinical risk s...
Eligibility Criteria
Inclusion
- Primary Care Provider that sees diabetes patients in clinic
Exclusion
- Provider does not see patients with Diabetes
Key Trial Info
Start Date :
February 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06593327
Start Date
February 10 2025
End Date
December 15 2027
Last Update
February 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Southwestern Medical Center
Dallas, Texas, United States, 75209